Where can I buy Athenex shares?
Shares of ATNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Athenex's stock price today?
When did Athenex go public?
(ATNX) raised $72 million in an IPO on Wednesday, June 14th 2017. The company issued 6,000,000 shares at $11.00-$13.00 per share. Credit Suisse, Deutsche, Bank Securities and J.P. Morgan served as the underwriters for the IPO and ICBC International was co-manager. What is Athenex's stock symbol?
What is Athenex's PE (earnings) ratio compared to its peers?
Earnings for Athenex are expected to grow in the coming year, from ($1.38) to ($0.88) per share. The P/E ratio of Athenex is -1.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What is the old name of Athenex?
The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York.
See more
Is Athenex stock a good buy?
Athenex has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Why Is ATNX Stock down?
Athenex stock plunges to pace all decliners after disappointing FDA response to breast cancer treatment NDA.
Will Athenex go back up?
On average, Wall Street analysts predict that Athenex's share price could reach $4.00 by Mar 17, 2023. The average Athenex stock price prediction forecasts a potential upside of 661.9% from the current ATNX share price of $0.53.
What is going on with Athenex?
The FDA ruled in February 2021 that Athenex's leading therapy – an oral formulation of popular chemotherapy drug that proposed to be both more effective and less toxic – needed to undergo a new clinical trial before it was fully approved. Athenex stock has tumbled from $12 at that time to less than $1 now.
What is happening with Athenex?
Related. The FDA rejected Athenex's drug, an oral version of the chemotherapy paclitaxel, in metastatic breast cancer in February 2021. After receiving feedback from the agency, the company decided to stop pursuing the approval in the U.S. in October 2021.
Should I buy or sell Athenex stock right now?
4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Athenex in the last twelve months. There are currently 3...
What is Athenex's stock price forecast for 2022?
4 brokers have issued 1 year price targets for Athenex's shares. Their forecasts range from $3.00 to $5.00. On average, they expect Athenex's share...
How has Athenex's stock performed in 2022?
Athenex's stock was trading at $1.36 on January 1st, 2022. Since then, ATNX stock has decreased by 63.2% and is now trading at $0.5001. View the b...
When is Athenex's next earnings date?
Athenex is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for Athenex .
How were Athenex's earnings last quarter?
Athenex, Inc. (NASDAQ:ATNX) issued its quarterly earnings data on Tuesday, May, 10th. The company reported ($0.16) earnings per share (EPS) for the...
Who are Athenex's key executives?
Athenex's management team includes the following people: Dr. Yiu-Nam Lau F.R.C.P. , M.B.B.S., M.D., Ph.D., Chairman & CEO (Age 62, Pay $547.73k)...
Who are some of Athenex's key competitors?
Some companies that are related to Athenex include Silence Therapeutics (SLN) , Provention Bio (PRVB) , Pliant Therapeutics (PLRX) , Biomea Fus...
What other stocks do shareholders of Athenex own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Athenex investors own include NVIDIA (NVDA) , Micron Tech...
When did Athenex IPO?
(ATNX) raised $72 million in an initial public offering on Wednesday, June 14th 2017. The company issued 6,000,000 shares at $11.00-$13.00 per shar...
What is the P/E ratio of Athenex?
What is the symbol for Athenex?
The P/E ratio of Athenex is -1.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Is Athenex a hold stock?
Athenex trades on the NASDAQ under the ticker symbol "ATNX."
Does Athenex pay dividends?
Wall Street analysts have given Athenex a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Athenex wasn't one of them.
Share your Analysis on ATNX
Athenex does not currently pay a dividend.
Company Profile
Join our contributor community and share your insights with millions of readers across the globe. Submit an article now
Transparency is our policy. Learn how it impacts everything we do
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
What is Athenex Inc?
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.
What time do you trade in the pre market?
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities throu
Does market cap include convertible securities?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.